• Clinical and pathological findings to be presented from clinical trial of the Bria-IMT™ regimen ...
BERKELEY, Calif., and VANCOUVER, British Columbia, October 1, 2020 — BriaCell Therapeutics Corp. (“BriaCell” or ...
BERKELEY, Calif., and VANCOUVER, British Columbia, September 15, 2020 — BriaCell Therapeutics Corp. (“BriaCell” or ...
BERKELEY, Calif., and VANCOUVER, British Columbia, September 4, 2020 — BriaCell Therapeutics Corp. (“BriaCell” or ...
BERKELEY, Calif., and VANCOUVER, British Columbia, August 17, 2020 — BriaCell Therapeutics Corp. (“BriaCell” or ...
Preliminary safety and efficacy data are being presented today from the clinical trials of Bria-IMT™ ...
BERKELEY, Calif., and VANCOUVER, British Columbia, August 11, 2020 — BriaCell Therapeutics Corp. (“BriaCell” or ...
BERKELEY, Calif., and VANCOUVER, British Columbia, June 24, 2020 — BriaCell Therapeutics Corp. (“BriaCell” or ...
Preliminary safety and efficacy data is being presented today from the clinical trials of Bria-IMT™ ...
BERKELEY, Calif., and VANCOUVER, British Columbia, June 9, 2020 — BriaCell Therapeutics Corp. (“BriaCell” or ...
Accessibility Tools